No 02 2023

Finnish ophthalmic device maker Revenio's iCare DRSplus fundus camera is now part of the first FDA-cleared AI-based diabetic retinopathy screening solution to reach the US market, through a partnership with health-tech company iHealthScreen.

Swedish biotech BioInvent has published preclinical data on its two anti-TNFR2 antibodies, BI-1808 and BI-1910, in the journal Cancer Research, showing the two candidates drive anti-tumour immunity through distinct mechanisms – including in tumour types that typically resist checkpoint inhibitor therapy.

Bio-Works Technologies has signed a new US customer, a major American biotech company, as a collaboration partner in the development of a new drug. The order is valued at SEK 2.8 million.

Finnish medtech company Koite Health has entered a research collaboration with Associated Brånemark Osseointegration Centers (ABOC), the global implantology network built on Professor Per-Ingvar Brånemark's osseointegration research, to study how at-home antibacterial care can be integrated into structured preventive protocols for dental implant patients.

NLS asked the CEO and co-founder of Pixelgen about entrepreneurship in Sweden, the company's global commercialization strategy and the most exciting clinical applications of the company's Proxiome kit.

Researchers at the University of Turku, working with France's Gustave Roussy Institute, have identified a molecular mechanism that lets an aggressive subtype of colorectal cancer shield itself from chemotherapy and spread through the abdominal cavity – and shown that antibodies already used against other cancers can disrupt the process.

ALK-Abelló has appointed Jacob Glenting as Executive Vice President and head of Global R&D, effective 1 September.